R ift Valley fever virus (RVFV) usually causes large, explosive epidemics among animals and humans and circulates in many African countries and the Arabian Peninsula (1-3). The human and veterinary medical role of this mosquito-borne virus was highlighted at the end of 2006 and early 2007, when a large epidemic/epizootic occurred in eastern Africa (4, 5) and Madagascar, during 2 successive rainy seasons (6, 7) . More recently, South Africa and Mauritania were severely affected (8, 9) . This wide dissemination potential emphasizes that Rift Valley fever constitutes a threat for human and animal health on the African continent and beyond. In Mayotte in July 2007, recent RVFV infection was detected in a 12-yearold boy with a severe neuroinvasive illness. This patient had recently arrived from Grande Comore, Union of the Comoros, where RVFV circulation had been confi rmed (10) (11) (12) .
Starting in April 2008, given the proximity of Comoros and Mayotte and considering the risk for introducing RVFV by illegal animal movements, active laboratory-based surveillance for Rift Valley fever was implemented among susceptible ruminants in Mayotte. A series of 4 serosurveys was designed to clarify the epidemiologic situation. The fi rst survey captured information about goats and cattle illegally introduced to the northern part of the island of Mayotte, the site of most illegal imports because of its proximity with the Comoros island of Anjouan (Figure 1 
The Study
The fi rst survey, intended to clarify the Rift Valley fever epidemiologic situation on the island, was undertaken in the M'Tsangamouji area (northern part of Mayotte). It examined samples from 29 illegally introduced goats and 79 cattle born on the island and living near the goats. Among the 29 goats, competitive IgG ELISA found IgG against RVFV in 4 goats that had been introduced illegally during November 2007-April 2008 (13) , and IgM-capture ELISA found IgM against RVFV in 2 goats (14), suggesting recent infection. Among the 79 cattle, IgG against RVFV was found in 29 (37%) and IgM against RVFV was found in 3 (4%).
These data led us to conduct the second survey, a retrospective study on the whole island to defi ne the geographic distribution of the infection and to trace back the period of introduction. This survey analyzed 301 cattle (Table) . The overall apparent RVFV seroprevalence of 10.6% (95% CI 7%-14%) was supported by the high specifi city of the ELISA (14) . The 32 positive samples came from cattle distributed all over the island (Figure 2, panel A) . It is unclear why relatively high circulation of RVFV in Mayotte and an increased rate of seroprevalence to 22% did not result in detectable clinical cases in animals while Rift Valley fever was diagnosed for humans with brain disorders (11) . This fi nding might be because the density of susceptible animals on the island was high enough to support virus circulation but too low to support waves of epidemic abortion and death. These study fi ndings, coupled with epidemics in eastern Africa, illustrate the risk for introduction of infectious agents from the African mainland to Mayotte or other Comoros islands. Entomologic studies need to be conducted to identify all potential vector species on the island and to better understand the ecologic and climatic factors that favor RVFV dissemination. The ecologic factors in favor of Rift Valley fever outbreaks might be comparable between Mayotte, the other Comoros islands, Madagascar, and the eastern African mainland (Kenya, Tanzania, and Mozambique) but need to be looked at more closely. In Mayotte, an entomologic surveillance program is being developed to help defi ne the distribution of potential vectors in association with virus circulation and provide better understanding of disease spread mechanisms. The role of wildlife should also be investigated. These data highlight the need for extensive studies to determine RVFV distribution and to evaluate the effect of Rift Valley fever on the susceptible livestock populations.
